NephroPlus (Nephrocare Health Services) IPO is scheduled to list on 17 Dec 2025 on NSE, BSE.
Listed
Mainboard IPO
NEPHROPLUS
NephroPlus (Nephrocare Health Services) IPO Listing Price Today
NephroPlus (Nephrocare Health Services) IPO listed on 17 Dec 2025 at ₹490 against an issue price of ₹460, a listing gain of +6.52%.
- Issue price
- ₹460
- Actual listing price
- ₹490
- Listing Date
- 17 Dec 2025
- Exchange
- NSE, BSE
Live share price
NephroPlus (Nephrocare Health Services) share price
-
vs issue price
Open-
Day high-
Day low-
Exchange-
Loading live price…
The live price isn't available right now. Check back shortly.
Source: Yahoo Finance. Prices may be delayed by a few minutes.
GMP vs actual
NephroPlus (Nephrocare Health Services) listing price vs GMP estimate
| Issue price | ₹460 |
|---|---|
| Latest GMP | ₹30 (+6.52%) |
| Expected listing price (issue price + GMP) | ₹490 |
| Actual listing price | ₹490 |
| Listing gain | +6.52% |
| Difference from GMP estimate | +₹0 (+0.00%) |
GMP is an unofficial grey market indicator, not a guarantee of the listing price.
Empirical GMP Accuracy:
Across 117 Indian IPOs, positive GMP predicted positive listing gains 69.8% of the time (72.2% of Mainboard IPOs opened within 10% of their GMP estimate).
View Research Report →
Listing day
Listing day timings
| Listing Date | 17 Dec 2025 |
|---|---|
| Special pre-open session | 9:00 AM - 9:45 AM |
| Normal trading starts | 10:00 AM |
| Exchange | NSE, BSE |
FAQ
NephroPlus (Nephrocare Health Services) IPO: frequently asked questions
NephroPlus (Nephrocare Health Services) IPO listed at ₹490 against an issue price of ₹460, a listing gain of +6.52%.
On listing day, a special pre-open session runs from 9:00 AM to 9:45 AM to set the listing price. NephroPlus (Nephrocare Health Services) shares then start normal trading at 10:00 AM.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.